Skip to Content
Merck
CN
All Photos(2)

Key Documents

View All Documentation

Safety Information

B1935

Sigma-Aldrich

Butorphan S(+)-mandelate

≥98% (HPLC), solid

Synonym(s):

(−)-3-Hydroxy-N-cyclobutylmethylmorphinan S(+)-mandelate, MCL-101 Mandelate

Sign Into View Organizational & Contract Pricing
All Photos(2)

About This Item

Empirical Formula (Hill Notation):
C21H29NO · C8H8O3
Molecular Weight:
463.61
UNSPSC Code:
12352202
PubChem Substance ID:
329773199

Assay

≥98% (HPLC)

form

solid

color

light yellow

solubility

DMSO: ~5 mg/mL

originator

Bristol-Myers Squibb

SMILES string

O[C@H](C(O)=O)c1ccccc1.Oc2ccc3C[C@@H]4C5CCCC[C@]5(CCN4CC6CCC6)c3c2

InChI

1S/C21H29NO.C8H8O3/c23-17-8-7-16-12-20-18-6-1-2-9-21(18,19(16)13-17)10-11-22(20)14-15-4-3-5-15;9-7(8(10)11)6-4-2-1-3-5-6/h7-8,13,15,18,20,23H,1-6,9-12,14H2;1-5,7,9H,(H,10,11)/t18?,20-,21-;7-/m10/s1

InChI key

CBWUCCIELNNDND-QADVRDRQSA-N

Biochem/physiol Actions

κ/μ opioid receptor agonist.

Features and Benefits

This compound was developed by Bristol-Myers Squibb. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Pictograms

Exclamation markEnvironment
GHS07,GHS09

Signal Word

Warning

Hazard Statements

H302,H410

Precautionary Statements

P273 - P501

Hazard Classifications

Acute Tox. 4 Oral - Aquatic Acute 1 - Aquatic Chronic 1

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Regulatory Information

新产品

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
014K4701

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

J L Neumeyer et al.
Journal of medicinal chemistry, 43(1), 114-122 (2000-01-14)
This report concerns the synthesis and preliminary pharmacological evaluation of a novel series of kappa agonists related to the morphinan (-)-cyclorphan (3a) and the benzomorphan (-)-cyclazocine (2) as potential agents for the pharmacotherapy of cocaine abuse. Recent evidence suggests that

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service